Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
ELCC 2017
The 7th European Lung Cancer Conference
Access to all presentations that took place at ELCC 2017 in Geneva, Switzerland
Presentation Date(s):- May 5 – 8, 2017
- Total Presentations: 359
-
+
Management of non-oncogene driven NSCLC
- Type: Specialty Session
- Presentations: 5
- Moderators:W.E.E. Eberhardt
- Coordinates: 5/06/2017, 11:00 - 12:30, Room B
-
+
Second line treatment and beyond: Selecting new agents in the arena for subsequent therapy
11:40 - 12:00 | Author(s): L. Horn
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Targeted therapies and management of brain metastasis
- Type: Proffered Paper session
- Presentations: 7
- Moderators:D.P. Carbone
- Coordinates: 5/06/2017, 16:45 - 18:15, Room A
-
+
86O - Afatinib (A) plus cetuximab (C) in the treatment of patients (pts) with NSCLC: The story so far
16:57 - 17:09 | Author(s): E. Smit
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
88O - CNS activity of ensartinib in ALK+ non-small cell lung cancer (NSCLC) patients (pts)
17:48 - 18:00 | Author(s): K.L. Reckamp
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Management of NSCLC with resistance to first line targeted therapy
- Type: Educational session
- Presentations: 5
- Moderators:L. Horn
- Coordinates: 5/07/2017, 09:00 - 10:30, Room B
-
+
Management of T790M positive disease after EGFR TKI failure
09:00 - 09:20 | Author(s): L. Horn
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Management of T790M negative disease after EGFR TKI failure
09:20 - 09:40 | Author(s): M. Krebs
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Management of drug resistance in ALK positive NSCLC
09:40 - 10:00 | Author(s): D.S. Tan
- Abstract
No abstract available for this presentation
-
+
Management of resistance in other targets beyond ALK and EGFR
10:00 - 10:20 | Author(s): L. Friboulet
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Questions and Answers
10:20 - 10:30
- Abstract
No abstract available for this presentation
-
+
Poster Display Session
- Type: Poster Display Session
- Presentations: 142
- Coordinates: 5/07/2017, 12:30 - 13:00, Hall 1
-
+
58TiP - IMpower133: Phase I/III trial of first-line atezolizumab with carboplatin and etoposide in ES-SCLC
12:30 - 12:30 | Author(s): M. Reck
- Abstract
Loading... -
+
146TiP - EXalt3: A phase III study of ensartinib (X-396) in anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC)
12:30 - 12:30 | Author(s): L. Horn
- Abstract
Loading...
-
+
Targeted therapies and immunotherapies
- Type: Poster Discussion session
- Presentations: 10
- Moderators:S. Ekman
- Coordinates: 5/07/2017, 14:45 - 15:45, Room W
-
+
91PD_PR - Response to salvage chemotherapy following exposure to PD-1/PD-L1 inhibitors in patients with NSCLC
14:45 - 14:45 | Author(s): S.I. Rothschild
- Abstract
Loading...